Amesite’s Dr. Ann Marie Sastry Featured as Guest Speaker at the Newsmakers: Lesher Speaker Series
Amesite (NASDAQ: AMST) announced that its Founder and CEO, Dr. Ann Marie Sastry, spoke at the Lesher Foundation's Newsmakers Series on October 24, 2024. During her presentation, Dr. Sastry discussed AI's impact on healthcare, highlighting the potential market of 5.2 million RNs and 3.9 million caregivers. She emphasized that AI technology can now pass the U.S. Medical License Exam and argued it would be 'unethical not to use AI' in healthcare. Key topics included AI as a tool for enhancing human capabilities, its impact on job automation, the need for rapid business adoption, and ethical considerations.
Amesite (NASDAQ: AMST) ha annunciato che il suo fondatore e CEO, Dr. Ann Marie Sastry, ha parlato alla serie Newsmakers della Lesher Foundation il 24 ottobre 2024. Durante la sua presentazione, la Dr. Sastry ha discusso dell'impatto dell'IA sulla salute, evidenziando il potenziale mercato di 5,2 milioni di infermieri e 3,9 milioni di caregiver. Ha sottolineato che la tecnologia IA può ora superare l'esame di licenza medica degli Stati Uniti e ha sostenuto che sarebbe 'non etico non utilizzare l'IA' nella sanità. I temi principali includevano l'IA come strumento per migliorare le capacità umane, il suo impatto sull'automazione del lavoro, la necessità di un'adozione aziendale rapida e considerazioni etiche.
Amesite (NASDAQ: AMST) anunció que su fundadora y CEO, la Dra. Ann Marie Sastry, habló en la serie Newsmakers de la Fundación Lesher el 24 de octubre de 2024. Durante su presentación, la Dra. Sastry discutió sobre el impacto de la IA en la atención médica, destacando el mercado potencial de 5.2 millones de enfermeras y 3.9 millones de cuidadores. Enfatizó que la tecnología de IA ahora puede aprobar el Examen de Licencia Médica de EE. UU. y argumentó que sería 'no ético no usar IA' en la atención médica. Los temas clave incluyeron a la IA como herramienta para mejorar las capacidades humanas, su impacto en la automatización de trabajos, la necesidad de rápida adopción por parte de las empresas y consideraciones éticas.
Amesite (NASDAQ: AMST)는 설립자이자 CEO인 Ann Marie Sastry 박사가 2024년 10월 24일 Lesher Foundation의 Newsmakers 시리즈에서 연설했다고 발표했습니다. 그녀의 발표에서 Sastry 박사는 의료 분야에서의 AI의 영향에 대해 논의하며, 520만 명의 등록 간호사와 390만 명의 돌보미라는 잠재 시장을 강조했습니다. 그녀는 AI 기술이 이제 미국 의사 면허 시험에 합격할 수 있으며, 의료 분야에서 'AI를 사용하지 않는 것은 비윤리적'이라고 주장했습니다. 주요 주제로는 인간 역량을 향상시키기 위한 도구로서의 AI, 직무 자동화에 대한 영향, 신속한 비즈니스 채택의 필요성, 그리고 윤리적 고려 사항이 포함되었습니다.
Amesite (NASDAQ: AMST) a annoncé que sa fondatrice et PDG, Dr. Ann Marie Sastry, a pris la parole lors de la série Newsmakers de la Fondation Lesher le 24 octobre 2024. Au cours de sa présentation, Dr. Sastry a discuté de l'impact de l'IA sur les soins de santé, soulignant le marché potentiel de 5,2 millions d'infirmières et de 3,9 millions d'aidants. Elle a souligné que la technologie IA peut désormais réussir l'examen de licence médicale américain et a soutenu qu'il serait 'non éthique de ne pas utiliser l'IA' dans les soins de santé. Les sujets clés comprenaient l'IA comme outil pour améliorer les capacités humaines, son impact sur l'automatisation des emplois, la nécessité d'une adoption rapide par les entreprises et les considérations éthiques.
Amesite (NASDAQ: AMST) gab bekannt, dass die Gründerin und CEO, Dr. Ann Marie Sastry, am 24. Oktober 2024 bei der Newsmakers-Serie der Lesher Foundation sprach. Während ihrer Präsentation sprach Dr. Sastry über den Einfluss von KI im Gesundheitswesen und hob den potenziellen Markt von 5,2 Millionen Krankenschwestern und 3,9 Millionen Pflegekräften hervor. Sie betonte, dass KI-Technologie inzwischen die US-Medizinlizenzprüfung bestehen kann und argumentierte, dass es 'unethisch wäre, KI' im Gesundheitswesen nicht zu nutzen. Zu den wichtigsten Themen gehörten KI als Werkzeug zur Verbesserung menschlicher Fähigkeiten, die Auswirkungen auf die Automatisierung von Arbeitsplätzen, die Notwendigkeit einer schnellen Unternehmensadoption und ethische Überlegungen.
- Company targets large healthcare market opportunity with 5.2M RNs and 3.9M caregivers
- Strategic positioning in AI healthcare solutions development
- None.
DETROIT, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, announced today its Founder and CEO, Dr. Ann Marie Sastry, was featured as a guest speaker at the Lesher Foundation's Newsmakers: 24/25 Season on October 24, 2024, following Former U.S. Representative Liz Cheney, Former World #1 Tennis Player and Founder of Chris Evert Charities, Chris Evert, Host of CNN's Smerconish and Best-Selling Author, Michael Smerconish and other eminent thinkers and experts.
Dr. Sastry talked about the impact of AI, and said that “AI allows you to reimagine yourself, and your capabilities.” Commenting on the impact of AI in healthcare, Dr. Sastry said, “Technology exists that passes the U.S. Medical License Exam. Why wouldn’t I want my healthcare provider to use AI? In fact, it’s super crazy not to…we looked at this market and said, there are 5.2 million RNs and about 3.9 million caregivers, so we [at Amesite] said, ‘let’s go help them’... My firm belief is that collectively the impact will be profound…it will be considered unethical not to use AI [in healthcare].”
Key topics covered by Dr. Sastry included:
- AI as a tool for enhancing human capabilities, driven by human creativity.
- Generative AI's impact on jobs, automating tasks and shifting roles toward AI management.
- Need for rapid AI adoption in business to stay competitive.
- Ethical concerns around AI’s lack of empathy, emphasizing responsible use and regulation.
- AI’s role in transforming healthcare, offering personalized, scalable support that improves patient care.
A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/28c8a11b-dead-4b1b-8175-66c08bad9469
About Amesite Inc.
Amesite Inc. (Nasdaq: AMST) is a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, including its higher ed platform that offers professional learning. Leveraging its proprietary AI infrastructure, Amesite offers cutting-edge applications that cater to both individual and professional needs. NurseMagic™, the company’s mobile app for healthcare professionals, streamlines creation of nursing notes and documentation tasks, enhances patient communication, and offers personalized guidance to nurses on patient care, medications, and handling challenging workplace situations.
Forward Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations Contact:
MJ Clyburn
TraDigital IR
clyburn@tradigitalir.com
Sources:
- https://nacns.org/2021/05/national-association-of-clinical-nurse-specialists-releases-census-results/#:~:text=The%20NACNS%
202020% 20census%20was,practice%20and%20education%20of%20CNSs. - https://www.aanp.org/about/all-about-nps/np-fact-sheet
- https://www.aacnnursing.org/news-data/fact-sheets/nursing-workforce-fact-sheet
- https://www.pncb.org/cpns-numbers
- https://www.bls.gov/oes/2023/may/oes291123.htm
- https://www.bls.gov/oes/2023/may/oes291122.htm
- https://www.bls.gov/oes/2023/may/oes292061.htm
- https://www.bls.gov/oes/2023/may/oes311131.htm#(1)
- https://www.zippia.com/home-care-nurse-jobs/demographics/
- https://datausa.io/profile/soc/home-health-aides?redirect=true
- https://www.ahip.org/resources/caregivers-in-america
- https://www.zippia.com/support-specialist-jobs/demographics/
FAQ
What did Amesite CEO Dr. Ann Marie Sastry say about AI in healthcare at the Lesher Speaker Series?
What are the key markets Amesite (AMST) is targeting in healthcare?
What were the main topics discussed by Amesite (AMST) at the Lesher Speaker Series on October 24, 2024?
